CSOs want disability grants reinstated

CSOs want disability grants reinstated

Interactive Data Dashboards

Track the HIV & TB response

Live indicators, province breakdowns and downloadable data.

  • CSOs want disability grants reinstated

    The South African Social Security Agency’s decision to suspend temporary disability grants in December left over 210 000 beneficiaries without an income – including some DR TB patients who rely on this grant to stay on treatment. Elri Voigt investigates.

    ·

  • SAHPRA decision on ivermectin shifts heavy responsibility to doctors

    In allowing section 21 applications as part of a controlled compassionate access programme, SAHPRA has essentially shifted the responsibility for deciding whether the anti-parasitic ivermectin is safe and effective enough to be used in the treatment of COVID-19 to doctors. This places an enormous responsibility on doctors, writes Adele Baleta.

    ·

  • After a rough 17 years, is Biovac finally on track?

    South Africa has struggled to secure adequate stock of urgently needed COVID-19 vaccines. This has raised questions about the state of the country’s local vaccine manufacturing capacity and why, after almost two decades of government support, South Africa’s partially state-owned vaccine manufacturer Biovac is not better positioned to respond to the pandemic. Catherine Tomlinson investigates.

    ·

  • 400 people in SA with highly drug-resistant TB to get new three-drug regimen

    Treating highly drug-resistant forms of tuberculosis can take anything from nine to 24 months and patients have to contend with various unpleasant, and sometimes dangerous, side effects. A new six-month regimen made up of just three drugs that will be offered to 400 patients in South Africa might offer a better solution for some. Tiyese…

    ·

  • COVID-19: The evolving science behind long-COVID

    A study published in the Lancet medical journal confirms that the health effects of COVID-19 can linger months after someone has ‘recovered’. Kathryn Cleary asked local experts about the underlying science and whether the South African public healthcare system is ready for so-called long-COVID.

    ·

  • Health in 2021: Spotlight’s top 12 questions

    While COVID-19 will continue to make headlines for some time, 2021 will also be a critical year for healthcare reforms in South Africa and for various aspects of the country’s HIV and TB response. These are Spotlight’s top 12 healthcare questions for the year.

    ·

  • Sub-clinical TB: Fascinating SA research helps push frontiers of TB science

    While likely millions of people in South Africa have latent tuberculosis (TB) infection, only between three and 10% of these people ever fall ill with TB. Cutting-edge research conducted in South Africa has now taken us a significant step closer to a test that can predict who will and who will not fall ill with…

    ·

  • X-rays and AI could transform TB detection in SA, but red tape might delay things

    New World Health Organization guidance released this week endorses the wider use of chest X-rays and artificial intelligence for tuberculosis detection. Before these technologies can be fully utilised in South Africa, some regulatory and other issues will first have to be sorted out. Catherine Tomlinson reports.

    ·

  • COVID-19: Millions of injection devices will be needed for vaccines

    The delivery of a safe and effective COVID-19 vaccine once it becomes available in South Africa will be a complex and costly logistical exercise. Acquiring enough injection devices is part of crucial logistical planning to ensure rapid, equitable access to COVID-19 vaccines. Adele Baleta reports.

    ·